Emanuela Lovati

Title: Emanuela Lovati: Innovator in Pharmaceutical Chemistry

Introduction

Emanuela Lovati is a distinguished inventor based in Mendrisio, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. Her work focuses on the synthesis of compounds that have important applications in medical treatments.

Latest Patents

One of her latest patents is titled "Process for the synthesis of substituted chloromethyl dialkylphosphates." This patent discloses compounds that include phosphate and N-oxide prodrugs of the NK1 antagonist netupitant. These compounds are useful in the prevention and treatment of diseases, including emesis induced by chemotherapy. The patent also outlines methods for making di-tert-butyl (chloromethyl) phosphate, which is essential in the manufacture of such prodrugs. The process involves several chemical reactions, including the reaction of a dialkylphosphate salt with an acid to obtain the corresponding ester of phosphoric acid.

Another notable patent is for "Fosnetupitant chloride hydrochloride having improved stability." This patent describes a chemical structure that enhances the stability of fosnetupitant chloride hydrochloride, which is crucial for its effectiveness in medical applications.

Career Highlights

Emanuela has worked with Helsinn Healthcare SA, where she has applied her expertise in pharmaceutical development. Her innovative approaches have contributed to advancements in drug formulation and stability.

Collaborations

Throughout her career, Emanuela has collaborated with notable professionals in her field, including Luca Fadini and Peter Manini. These collaborations have further enriched her research and development efforts.

Conclusion

Emanuela Lovati is a prominent figure in pharmaceutical innovation, with a strong portfolio of patents that reflect her expertise and dedication to improving medical treatments. Her contributions continue to impact the field positively.